SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.
A ‘Vivid,’ Nuclear Opportunity Awaits Stock Investors As Analyst Points To A Recent Smart Home Acquisition
Shares of NRG Energy Inc (NYSE: NRG) spiked in early trading on Monday, after losing more than 22% over the past six months.
